These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23291201)

  • 1. A cyclic peptide mimic of an RNA recognition motif of human La protein is a potent inhibitor of hepatitis C virus.
    Manna AK; Kumar A; Ray U; Das S; Basu G; Roy S
    Antiviral Res; 2013 Mar; 97(3):223-6. PubMed ID: 23291201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific sequence of a Beta turn in human la protein may contribute to species specificity of hepatitis C virus.
    Kumar A; Manna AK; Ray U; Mullick R; Basu G; Das S; Roy S
    J Virol; 2014 Apr; 88(8):4319-27. PubMed ID: 24478427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peptide derived from RNA recognition motif 2 of human la protein binds to hepatitis C virus internal ribosome entry site, prevents ribosomal assembly, and inhibits internal initiation of translation.
    Pudi R; Ramamurthy SS; Das S
    J Virol; 2005 Aug; 79(15):9842-53. PubMed ID: 16014945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-Amino-2(5H)furanones as inhibitors of subgenomic hepatitis C virus RNA replication.
    Iannazzo D; Piperno A; Romeo G; Romeo R; Chiacchio U; Rescifina A; Balestrieri E; Macchi B; Mastino A; Cortese R
    Bioorg Med Chem; 2008 Nov; 16(21):9610-5. PubMed ID: 18835180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural determinant of human La protein critical for internal initiation of translation of hepatitis C virus RNA.
    Mondal T; Ray U; Manna AK; Gupta R; Roy S; Das S
    J Virol; 2008 Dec; 82(23):11927-38. PubMed ID: 18829760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hepatitis C virus life cycle as a target for new antiviral therapies.
    Pawlotsky JM; Chevaliez S; McHutchison JG
    Gastroenterology; 2007 May; 132(5):1979-98. PubMed ID: 17484890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An engineered inhibitor RNA that efficiently interferes with hepatitis C virus translation and replication.
    Romero-López C; Berzal-Herranz B; Gómez J; Berzal-Herranz A
    Antiviral Res; 2012 May; 94(2):131-8. PubMed ID: 22426470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation.
    Dash S; Prabhu R; Hazari S; Bastian F; Garry R; Zou W; Haque S; Joshi V; Regenstein FG; Thung SN
    Liver Int; 2005 Jun; 25(3):580-94. PubMed ID: 15910496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin B12 and hepatitis C: molecular biology and human pathology.
    Lott WB; Takyar SS; Tuppen J; Crawford DH; Harrison M; Sloots TP; Gowans EJ
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4916-21. PubMed ID: 11296247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics.
    Guedj J; Neumann AU
    J Theor Biol; 2010 Dec; 267(3):330-40. PubMed ID: 20831874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of β-turn in LaR2C-N7 peptide for its translation-inhibitory activity against hepatitis C viral infection: A molecular dynamics study.
    Chandra N; Biswas S; Rout J; Basu G; Tripathy U
    Spectrochim Acta A Mol Biomol Spectrosc; 2019 Mar; 211():26-33. PubMed ID: 30502581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus.
    Lamarre D; Anderson PC; Bailey M; Beaulieu P; Bolger G; Bonneau P; Bös M; Cameron DR; Cartier M; Cordingley MG; Faucher AM; Goudreau N; Kawai SH; Kukolj G; Lagacé L; LaPlante SR; Narjes H; Poupart MA; Rancourt J; Sentjens RE; St George R; Simoneau B; Steinmann G; Thibeault D; Tsantrizos YS; Weldon SM; Yong CL; Llinàs-Brunet M
    Nature; 2003 Nov; 426(6963):186-9. PubMed ID: 14578911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Hepatitis C virus-host interaction involved in viral replication: toward the identification of antiviral targets.
    Suzuki T
    Jpn J Infect Dis; 2010 Sep; 63(5):307-11. PubMed ID: 20858994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic monophosphate prodrugs of base-modified 2'-C-methyl ribonucleosides as potent inhibitors of hepatitis C virus RNA replication.
    Gunic E; Girardet JL; Ramasamy K; Stoisavljevic-Petkov V; Chow S; Yeh LT; Hamatake RK; Raney A; Hong Z
    Bioorg Med Chem Lett; 2007 May; 17(9):2452-5. PubMed ID: 17331721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a series of 1,3,4-trisubstituted pyrazoles as novel hepatitis C virus entry inhibitors.
    Hwang JY; Kim HY; Park DS; Choi J; Baek SM; Kim K; Kim S; Seong S; Choi I; Lee HG; Windisch MP; Lee J
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6467-73. PubMed ID: 24125883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
    Jarczak D; Korf M; Beger C; Manns MP; Krüger M
    FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PKR protein kinase is activated by hepatitis C virus and inhibits viral replication through translational control.
    Kang JI; Kwon SN; Park SH; Kim YK; Choi SY; Kim JP; Ahn BY
    Virus Res; 2009 Jun; 142(1-2):51-6. PubMed ID: 19189853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The recent progress on experimental models and molecular virology of hepatitis C virus].
    Zhong J
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):494-6. PubMed ID: 19912681
    [No Abstract]   [Full Text] [Related]  

  • 19. A peptide targeted against phosphoprotein and leader RNA interaction inhibits growth of Chandipura virus -- an emerging rhabdovirus.
    Roy A; Chakraborty P; Polley S; Chattopadhyay D; Roy S
    Antiviral Res; 2013 Nov; 100(2):346-55. PubMed ID: 24036128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of novel carbocyclic versions of 2'-spirocyclopropyl ribonucleosides as potent anti-HCV agents.
    Oh CH; Kim E; Hong JH
    Nucleosides Nucleotides Nucleic Acids; 2011 Jun; 30(6):423-39. PubMed ID: 21780908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.